140 results
ARS
2023 FY
XFOR
X4 Pharmaceuticals Inc
29 Apr 24
Annual report to shareholders
4:58pm
be no assurance that any of our pending patent applications will issue or that we will benefit from any patent term extension or other favorable …
differentials between E.U. member states. There can be no assurance that any country that has price controls or reimbursement limitations
8-K
XFOR
X4 Pharmaceuticals Inc
14 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:10pm
determination to a hearings panel pursuant to the procedures set forth in the applicable Nasdaq Listing Rules. However, there can be no assurance … potentially seeking to effect a reverse stock split. There can be no assurance that the Company will be able to regain compliance with the Bid Price
S-8
EX-5
tr8r0s wywi
11 Aug 23
Registration of securities for employees
8:38pm